Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
68.05
Change Change %
2.15 3.26%

Updated:27 Oct, 2021, 16:13 PM IST

BSE
68.00
Change Change %
2.10 3.19%

Updated:27 Oct, 2021, 16:00 PM IST

Marksans Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18 MAR'17
Operational & Financial Ratios:
   Earnings Per Share (Rs) 0.30 0.28
   DPS(Rs) 0.05 0.05
   Book NAV/Share(Rs) 10.48 10.23
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 2.26 2.14
   ROE(%) 2.93 2.79
   ROCE(%) 4.92 3.44
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 104.24 167.16
   PCE(x) 52.50 72.70
   Price / Book(x) 3.02 4.61
   Yield(%) 0.16 0.11
   EV / Net Sales(x) 4.62 9.27
   EV / Core EBITDA(x) 37.23 63.63
   EV / EBIT(x) 55.99 121.71
   EV / CE(x) 2.45 3.67
   M Cap / Sales 4.40 8.94
Growth Ratio:
   Core Operating Income Growth 70.77 -27.62
   Operating Profit Growth 16.33 -72.07
   Net Profit Growth 7.64 -83.85
   BVPS Growth 2.41 2.12
   Advances Growth 0.00 0.00
   EPS Growth(%) 7.64 -83.85
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top
Listen to the latest songs, only on JioSaavn.com